Fmoc-Ser(Tbu)-Oh Bulk Price 2026: Industrial Procurement Outlook
- 2026 bulk pricing for Fmoc-O-tert-Butyl-L-serine is driven by optimized synthesis routes and raw material volatility.
- Industrial-grade purity (>98.5%) and full documentation (COA, PS, SDS) are critical for GMP peptide manufacturing.
- NINGBO INNO PHARMCHEM CO.,LTD. offers scalable supply with competitive per-kilogram rates for multi-kilo orders.
As peptide therapeutics continue to expand in oncology, metabolic disease, and targeted drug delivery, demand for high-quality, protected amino acids like Fmoc-O-tert-Butyl-L-serine (CAS: 71989-33-8) has surged globally. Known chemically as (2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[(2-methylpropan-2-yl)oxy]propanoic acid, this building block is essential for solid-phase peptide synthesis (SPPS), where the tert-butyl group protects the serine hydroxyl during chain elongation. With 2026 approaching, B2B buyers are prioritizing not just cost, but supply reliability, batch-to-batch consistency, and regulatory compliance.
2026 Bulk Pricing Drivers for Fmoc-Ser(tBu)-OH
The bulk price of Fmoc-Ser(tBu)-OH in 2026 hinges on several interrelated factors:
- Synthesis route efficiency: The standard industrial method involves Fmoc-Cl coupling with O-tert-butyl-L-serine under controlled pH and temperature. Advances in catalytic systems and solvent recovery have reduced waste and improved yields, directly lowering production costs.
- Raw material availability: Fluctuations in fluorenylmethyloxycarbonyl chloride (Fmoc-Cl) and tert-butanol derivatives impact input costs. Geopolitical supply chain disruptions can cause short-term price spikes.
- Purity and analytical validation: Buyers increasingly require ≥98.5% industrial purity with full Certificates of Analysis (COA), HPLC chromatograms, and chiral integrity data—standards that influence final pricing tiers.
While spot-market listings may show prices around $40–$50 per gram for small quantities, these are not representative of true bulk price structures. Multi-kilogram or metric-ton contracts typically see significant volume discounts, especially when sourced directly from an integrated global manufacturer.
Technical Specifications & Quality Assurance
High-performance peptide synthesis demands stringent quality control. NINGBO INNO PHARMCHEM CO.,LTD. produces Fmoc-Ser(tBu)-OH to meet or exceed international pharmacopeial standards, with the following key attributes:
| Property | Specification |
|---|---|
| CAS Number | 71989-33-8 |
| Molecular Formula | C22H25NO5 |
| Molecular Weight | 383.4 g/mol |
| Appearance | White to off-white crystalline powder |
| Purity (HPLC) | ≥98.5% |
| Solubility | ≥38.3 mg/mL in DMSO; ≥97.4 mg/mL in ethanol; insoluble in water |
| Storage | -20°C, desiccated, under inert atmosphere |
Every batch is accompanied by a comprehensive Product Specification (PS), Safety Data Sheet (SDS), and Certificate of Analysis (COA), ensuring traceability and compliance with ICH Q7 and FDA guidelines for active pharmaceutical ingredient (API) intermediates.
Strategic Sourcing from a Premier Global Manufacturer
When sourcing high-purity Fmoc-O-tert-Butyl-L-serine, buyers should prioritize suppliers with vertical integration, cGMP-aligned facilities, and a proven track record in amino acid chemistry. NINGBO INNO PHARMCHEM CO.,LTD. stands out as a premier global manufacturer, offering end-to-end control over the manufacturing process—from raw material qualification to final packaging.
By optimizing the synthesis route and implementing rigorous in-process controls, the company achieves consistent reaction yields above 85%, minimizing impurities such as diastereomers or residual solvents. This technical excellence translates into stable, predictable bulk price structures for 2026, even amid market volatility.
For contract manufacturers and pharmaceutical R&D teams, securing long-term supply agreements now can lock in favorable rates ahead of anticipated demand surges in GLP-1 analogs, antimicrobial peptides, and cancer vaccines—all of which rely heavily on protected serine derivatives.
Conclusion: Value Beyond the Price Tag
While the headline bulk price of Fmoc-Ser(tBu)-OH matters, total cost of ownership includes quality failures, supply delays, and regulatory risk. NINGBO INNO PHARMCHEM CO.,LTD. mitigates these through robust quality systems, scalable production capacity (multi-ton/year), and responsive technical support. As the 2026 procurement cycle begins, forward-looking buyers are engaging early to secure both pricing and allocation—ensuring uninterrupted development pipelines and commercial continuity.